Cargando…

Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation

Mutation(s) in the spike protein is the major characteristic trait of newly emerged SARS-CoV-2 variants such as Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Delta-plus. Omicron (B.1.1.529) is the latest addition and it has been characterized by high transmissibility and the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Nabarun Chandra, Chakraborty, Pritha, Bayry, Jagadeesh, Mukherjee, Suprabhat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045060/ https://www.ncbi.nlm.nih.gov/pubmed/36975364 http://dx.doi.org/10.3390/antib12010017

Ejemplares similares

In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein
por: Das, Nabarun Chandra, et al.
Publicado: (2022)

Therapeutic Efficacy of Anti-Bestrophin Antibodies against Experimental Filariasis: Immunological, Immune-Informatics and Immune Simulation Investigations
por: Das, Nabarun Chandra, et al.
Publicado: (2021)

Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings
por: Das, Nabarun Chandra, et al.
Publicado: (2023)

Wuchereria bancrofti filaria activates human dendritic cells and polarizes T helper 1 and regulatory T cells via toll-like receptor 4
por: Mukherjee, Suprabhat, et al.
Publicado: (2019)

Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants
por: Chakraborty, Sandipan, et al.
Publicado: (2022)

Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study
por: Das, Bhabani Shankar, et al.
Publicado: (2022)

Omicron variant evolution on vaccines and monoclonal antibodies
por: Sabbatucci, Michela, et al.
Publicado: (2023)

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
por: Choudhury, Abhigyan, et al.
Publicado: (2021)

Exploring the Differential Expression and Prognostic Significance of the COL11A1 Gene in Human Colorectal Carcinoma: An Integrated Bioinformatics Approach
por: Patra, Ritwik, et al.
Publicado: (2021)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
por: Hu, Ye-Fan, et al.
Publicado: (2022)

SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody
por: Omotuyi, Olaposi, et al.
Publicado: (2022)

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
por: Schulz, Sebastian R., et al.
Publicado: (2022)

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants
por: Chen, Zhaochun, et al.
Publicado: (2022)

Limits of Monoclonal Antibody Treatment in Pregnant Women Complicated with COVID-19 Due to The Omicron Variant
por: Cha, Hyun-Hwa, et al.
Publicado: (2022)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron
por: Zhou, Bing, et al.
Publicado: (2022)

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
por: Arora, Prerna, et al.
Publicado: (2023)

Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
por: Rocha, Letícia B., et al.
Publicado: (2012)

Obesity negatively impacts maintenance of antibody response to COVID-19 vaccines
por: Chauvin, Camille, et al.
Publicado: (2023)

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
por: Focosi, Daniele, et al.
Publicado: (2022)

Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis
por: Tao, Kaiming, et al.
Publicado: (2022)

Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern
por: Mazzaferri, Fulvia, et al.
Publicado: (2022)

Cocktail of REGN Antibodies Binds More Strongly to SARS-CoV-2 Than Its Components, but the Omicron Variant Reduces Its Neutralizing Ability
por: Nguyen, Hung, et al.
Publicado: (2022)

Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide
Publicado: (1993)

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
por: Fenwick, Craig, et al.
Publicado: (2022)

Protection from successive Omicron variants with SARS-CoV-2 vaccine and monoclonal antibodies in kidney transplant recipients
por: Moal, Valérie, et al.
Publicado: (2023)

Acid Stripping of Surface IgE Antibodies Bound to FcεRI Is Unsuitable for the Functional Assays That Require Long-Term Culture of Basophils and Entire Removal of Surface IgE
por: Galeotti, Caroline, et al.
Publicado: (2020)

Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

A novel plant‐made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS‐CoV‐2 Omicron variant
por: Jugler, Collin, et al.
Publicado: (2022)

Emerging viral diseases of livestock in the developing world
por: Bayry, Jagadeesh
Publicado: (2013)

Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy
por: Bayry, Jagadeesh
Publicado: (2013)

In silico investigation of the role of vitamins in cancer therapy through inhibition of MCM7 oncoprotein
por: Mukherjee, Sunny, et al.
Publicado: (2022)

Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022)

Ofatumumab Monoclonal Antibody Affinity Maturation Through in silico Modeling
por: Payandeh, Zahra, et al.
Publicado: (2018)

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period
por: Fomina, Daria S., et al.
Publicado: (2023)

Cross-presentation of antigens by dendritic cells: role of autophagy
por: Das, Mrinmoy, et al.
Publicado: (2015)

Regulatory T cells do not suppress rather activate human basophils by IL-3 and STAT5-dependent mechanisms
por: Das, Mrinmoy, et al.
Publicado: (2020)

Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
por: Boschi, Céline, et al.
Publicado: (2022)

In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies
por: Urban, Aleksandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ofsns425r6uttnm11hb563ccqp